George H. Hitchings
Scientists

George H. Hitchings Net Worth

George H. Hitchings was an American doctor who was one of the co-recipients of the 1988 Nobel Prize in Physiology or Medicine. He was born in Hoquiam, Washington in 1905 and was inspired to become a doctor after his father's untimely death. He attended the University of Washington and Harvard University, where he earned a degree in chemistry and a doctorate, respectively. He then went on to collaborate with Gertrude Elion at Wellcome Research Laboratories, where they developed life-saving drugs to treat diseases like leukemia, gout, and disorders of the human immunity system. This work earned them the Nobel Prize in 1988.
George H. Hitchings is a member of Scientists

Age, Biography and Wiki

Who is it? Physiologist
Birth Day April 18, 1905
Birth Place Hoquiam, Washington, United States, United States
Age 115 YEARS OLD
Died On February 27, 1998 (1998-02-28) (aged 92)
Birth Sign Taurus
Alma mater University of Washington Harvard University
Known for chemotherapy
Awards Gairdner Foundation International Award (1968) ForMemRS (1974) Nobel Prize in Physiology or Medicine (1988)
Institutions Case Western Reserve University Duke University

💰 Net worth

George H. Hitchings, a renowned physiologist in the United States, is projected to have a net worth ranging from $100K to $1M by the year 2024. Hitchings' significant contributions to the field of physiology have propelled him to great heights in his career and have garnered him substantial recognition. With a remarkable body of work and countless accomplishments under his belt, his estimated net worth reflects his success in both professional and financial aspects of his life.

Biography/Timeline

1905

Hitchings was born in Hoquiam, Washington, in 1905, and grew up there, in Berkeley, California, San Diego, Bellingham, Washington, and Seattle. He graduated from Seattle's Franklin High School, where he was salutatorian, in 1923, and from there went to the University of Washington, from which he graduated with a degree in chemistry cum laude in 1927, after having been elected to Phi Beta Kappa as a junior the year before. That summer, he worked at the university's Puget Sound Biological Station at Friday Harbor on San Juan Island [1], and received a master's degree the next year for his thesis based on that work.

1933

From the University of Washington, Hitchings went to Harvard University as a teaching fellow, ending up at Harvard Medical School. Before getting his Ph.D. in 1933, he joined Alpha Chi Sigma in 1929.

1942

Following his PhD, he worked at Harvard and Case Western Reserve University. In 1942, he went to work for Wellcome Research Laboratories, where he began working with Gertrude Elion in 1944. Drugs Hitchings' team worked on included 2,6-diaminopurine (a compound to treat leukemia) and p-chlorophenoxy-2,4-diaminopyrimidine (a folic acid antagonist). According to his Nobel Prize autobiography,

1967

In 1967 Hitchings became Vice President in Charge of Research of Burroughs-Wellcome. He became Scientist Emeritus in 1976. He also served as Adjunct Professor of Pharmacology and of Experimental Medicine from 1970 to 1985 at Duke University. Hitchings died in 1998 in Chapel Hill, North Carolina. Hitchings founded the Triangle Community Foundation in 1983. Hitchings is a member of the Medicinal Chemistry Hall of Fame. His wife died in 1985.

1969

Hitchings was awarded the Passano award by the Passano Foundation in 1969, and the de Villiers award in 1970. He was elected a Foreign Member of the Royal Society (ForMemRS) in 1974.

Some George H. Hitchings images

About the author

Lisa Scholfield

As a Senior Writer at Famous Net Worth, I spearhead an exceptional team dedicated to uncovering and sharing the stories of pioneering individuals. My passion for unearthing untold narratives drives me to delve deep into the essence of each subject, bringing forth a unique blend of factual accuracy and narrative allure. In orchestrating the editorial workflow, I am deeply involved in every step—from initial research to the final touches of publishing, ensuring each biography not only informs but also engages and inspires our readership.